These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 2852381)
41. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC). Bensadoun RJ; Bénézery K; Dassonville O; Magné N; Poissonnet G; Ramaïoli A; Lemanski C; Bourdin S; Tortochaux J; Peyrade F; Marcy PY; Chamorey E; Vallicioni J; Seng H; Alzieu C; Géry B; Chauvel P; Schneider M; Santini J; Demard F; Calais G Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):983-94. PubMed ID: 16376489 [TBL] [Abstract][Full Text] [Related]
42. [Clinical and histopathological studies on radiotherapy for hypopharyngeal carcinoma--factors determining the outcome of the therapy]. Takashima H; Amatsu M Nihon Gan Chiryo Gakkai Shi; 1983 Jun; 18(4):906-15. PubMed ID: 6619640 [No Abstract] [Full Text] [Related]
46. [Results of irradiation by telecobalt at low dose rat, up to March 1973 (author's transl)]. Pierquin B; Baillet F; Raynal M; Marinello G; Turgard I J Radiol Electrol Med Nucl; 1974; 55(6-7):515-8. PubMed ID: 4425132 [No Abstract] [Full Text] [Related]
55. Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma. Yao M; Karnell LH; Funk GF; Lu H; Dornfeld K; Buatti JM Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1354-60. PubMed ID: 17689885 [TBL] [Abstract][Full Text] [Related]
56. [Radiotherapy of malignant neoplasms of the maxillary sinus. (Clinico-statistical contribution)]. Corinaldesi A; Cecchetti E; Roversi R; Cammoranesi L Radiobiol Radioter Fis Med; 1968; 23(3):149-86. PubMed ID: 4307164 [No Abstract] [Full Text] [Related]
57. Radiotherapy for postoperative persistent cancer of the head and neck. Hoover SV; Moss WT Otolaryngol Clin North Am; 1974 Feb; 7(1):175-92. PubMed ID: 4360034 [No Abstract] [Full Text] [Related]
58. Tumor expression of major vault protein is an adverse prognostic factor for radiotherapy outcome in oropharyngeal carcinoma. Silva P; West CM; Slevin N; Valentine H; Ryder WD; Hampson L; Bibi R; Sloan P; Thakker N; Homer J; Hampson I Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):133-40. PubMed ID: 17459603 [TBL] [Abstract][Full Text] [Related]
59. [Treatment results in nasopharyngeal cancer following cobalt teletherapy]. Ziegler F; Metzger H; Hübener KH Strahlentherapie Sonderb; 1984; 78():90-2. PubMed ID: 6729914 [No Abstract] [Full Text] [Related]
60. Irradiation scheme using three daily fractions in the radiation therapy of pharyngeal and oral carcinomas. Durkovský J; Jancina J; Siracká E; Krajci M Neoplasma; 1984; 31(2):213-22. PubMed ID: 6717690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]